Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1Breast 1

Conditions

Sleep Apnea, Obstructive 2Sleep Apnea Syndromes 2Polycystic Ovary Syndrome 2Neoplasms 2Lung Neoplasms 2Unilateral Breast Neoplasms 1Obesity 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Continuous Positive Airway Pressure × Clear all
NCT05142358 2026-02-02

A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose

Case Comprehensive Cancer Center

Phase NA Completed
8 enrolled
BreastThoracic

Unilateral Breast Neoplasms, Lung Neoplasms, Neoplasms

NCT02852473 2016-10-14

Impact of Continuous Positive Airway Pressure on Breathing Motion Amplitude

Mayo Clinic

Phase EARLY_PHASE1 Completed
10 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡